Ashley Woods

764 total citations
17 papers, 543 citations indexed

About

Ashley Woods is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ashley Woods has authored 17 papers receiving a total of 543 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ashley Woods's work include Acute Myeloid Leukemia Research (4 papers), CAR-T cell therapy research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Ashley Woods is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), CAR-T cell therapy research (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Ashley Woods collaborates with scholars based in United States, United Kingdom and South Korea. Ashley Woods's co-authors include Peter G. Schultz, Travis S. Young, Danling Wang, Reza Beheshti Zavareh, Francisco Martínez‐Peña, J. González, Luke L. Lairson, Michele A. Steffey, Michael Hesse and Robert Doran and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Blood.

In The Last Decade

Ashley Woods

15 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Woods United States 10 290 210 124 97 88 17 543
Louis H. Bookbinder United States 7 253 0.9× 176 0.8× 64 0.5× 62 0.6× 74 0.8× 7 641
Masatoshi Nishizawa Japan 8 560 1.9× 115 0.5× 136 1.1× 143 1.5× 28 0.3× 16 782
Peter Karagiannis Japan 13 396 1.4× 88 0.4× 67 0.5× 80 0.8× 74 0.8× 24 603
Thomas Moreau United Kingdom 10 240 0.8× 117 0.6× 58 0.5× 61 0.6× 54 0.6× 19 441
Maura C. Kibbey United States 9 220 0.8× 112 0.5× 104 0.8× 59 0.6× 56 0.6× 11 597
Patricia E. de Almeida United States 9 600 2.1× 158 0.8× 176 1.4× 140 1.4× 121 1.4× 10 843
Valeria Fernández Vallone Argentina 15 273 0.9× 297 1.4× 104 0.8× 63 0.6× 69 0.8× 27 632
Jaeger Davis United States 5 287 1.0× 66 0.3× 70 0.6× 66 0.7× 105 1.2× 5 534
Reshma A. Lalai Netherlands 13 253 0.9× 105 0.5× 95 0.8× 70 0.7× 79 0.9× 21 515
Esra Çağavi Türkiye 10 428 1.5× 114 0.5× 127 1.0× 80 0.8× 38 0.4× 21 666

Countries citing papers authored by Ashley Woods

Since Specialization
Citations

This map shows the geographic impact of Ashley Woods's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Woods with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Woods more than expected).

Fields of papers citing papers by Ashley Woods

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Woods. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Woods. The network helps show where Ashley Woods may publish in the future.

Co-authorship network of co-authors of Ashley Woods

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Woods. A scholar is included among the top collaborators of Ashley Woods based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Woods. Ashley Woods is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Woods, Ashley, Dianne Pulte, Jonathon Vallejo, et al.. (2025). FDA Approval Summary: Ivosidenib for Treatment of Adult Patients with Relapsed/Refractory Myelodysplastic Syndrome with an IDH1 Mutation. Clinical Cancer Research. 31(17). 3613–3617. 1 indexed citations
2.
Woods, Ashley, Kelly J. Norsworthy, Moran Choe, et al.. (2024). FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation. Clinical Cancer Research. 31(1). 12–17. 1 indexed citations
3.
4.
Woods, Ashley, Kelly J. Norsworthy, Jonathon Vallejo, et al.. (2023). FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation. Clinical Cancer Research. 30(7). 1226–1231. 16 indexed citations
5.
Woods, Ashley & Kelly J. Norsworthy. (2023). Differentiation Syndrome in Acute Leukemia: APL and Beyond. Cancers. 15(19). 4767–4767. 11 indexed citations
6.
Pulte, Dianne, Laura L. Fernandes, Ashley Woods, et al.. (2023). FDA Analysis of Ineligibility for Acute Myeloid Leukemia Clinical Trials by Race and Ethnicity. Clinical Lymphoma Myeloma & Leukemia. 23(6). 463–470.e1. 6 indexed citations
7.
Woods, Ashley, Andrew L. Doedens, Yunyi Kang, et al.. (2021). IND-Enabling Studies of a Switchable Chimeric Antigen Receptor-T Cell (CLBR001+SWI019) to Support First in Human Clinical Study. Blood. 138(Supplement 1). 1695–1695.
8.
Zavareh, Reza Beheshti, et al.. (2020). HSP90 Inhibition Enhances Cancer Immunotherapy by Modulating the Surface Expression of Multiple Immune Checkpoint Proteins. Cell chemical biology. 28(2). 158–168.e5. 59 indexed citations
9.
Olson, Katherine E., Krista L. Namminga, Aaron Schwab, et al.. (2020). Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice. Neurotherapeutics. 17(4). 1861–1877. 25 indexed citations
10.
Muppidi, Avinash, Sang Jun Lee, Che‐Hsiung Hsu, et al.. (2018). Design and Synthesis of Potent, Long-Acting Lipidated Relaxin-2 Analogs. Bioconjugate Chemistry. 30(1). 83–89. 20 indexed citations
11.
Castrodeza, Javier, Ashley Woods, David Dobarro, et al.. (2018). Infection Predisposes to Thrombosis During Long Term VAD Support. The Journal of Heart and Lung Transplantation. 37(4). S362–S363.
12.
Yu, Shan, Reyna K. V. Lim, David T. Rodgers, et al.. (2017). P-262 A PDE4 Inhibitor-antibody Conjugate for Treating Ulcerative Colitis. Inflammatory Bowel Diseases. 23. 1 indexed citations
13.
Mazagova, Magdalena, Sida Shao, Xinxin Wang, et al.. (2017). Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. International Journal of Molecular Sciences. 18(11). 2259–2259. 58 indexed citations
14.
Liu, Tao, Yong Zhang, Yan Liu, et al.. (2015). Functional human antibody CDR fusions as long-acting therapeutic endocrine agonists. Proceedings of the National Academy of Sciences. 112(5). 1356–1361. 29 indexed citations
15.
Kim, Min Soo, S. Y. Jennifer, Hwayoung Yun, et al.. (2015). Redirection of Genetically Engineered CAR-T Cells Using Bifunctional Small Molecules. Journal of the American Chemical Society. 137(8). 2832–2835. 147 indexed citations
16.
Tallini, Yvonne N., Kai Su Greene, Michael Craven, et al.. (2009). c-kit expression identifies cardiovascular precursors in the neonatal heart. Proceedings of the National Academy of Sciences. 106(6). 1808–1813. 159 indexed citations
17.
Woods, Ashley & Kenneth B. Storey. (2007). Cytosolic phospholipase A2 regulation in the hibernating thirteen-lined ground squirrel. Cellular & Molecular Biology Letters. 12(4). 621–32. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis H. Bookbinder Breakdown of academic impact, for papers by Masatoshi Nishizawa Breakdown of academic impact, for papers by Peter Karagiannis Breakdown of academic impact, for papers by Thomas Moreau Breakdown of academic impact, for papers by Maura C. Kibbey Breakdown of academic impact, for papers by Patricia E. de Almeida Breakdown of academic impact, for papers by Valeria Fernández Vallone Breakdown of academic impact, for papers by Jaeger Davis Breakdown of academic impact, for papers by Reshma A. Lalai Breakdown of academic impact, for papers by Esra Çağavi
Rankless by CCL
2026